Osteoprotegerin administrated by non viral gene transfer decreased lytic bone lesions and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL produced by tumor cells
Journal article published in 2011 by
Gaelle Picarda,
Etienne Matous,
Soizic Hervouet,
Benoit Barteau,
Franck Tirode 
,
Francois Lamoureux,
Bruno Pitard,
Dominique Heymann,
Valerie Trichet,
Francoise Redini
,
Francois Lamoureux,
Bruno Pitard,
Dominique Heymann,
Valerie Trichet,
Francoise Redini
